tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA

Verona Pharma (VRNA) Technical Analysis

481 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 16.27, while Verona Pharma Plc’s (VRNA) share price is $16.09, making it a Sell.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 16.65, while Verona Pharma Plc’s (VRNA) share price is $16.09, making it a Sell.

Verona Pharma (VRNA) Pivot Points

Apr 28, 2024, 01:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.99
15.40
15.95
16.36
16.91
17.32
17.87
Fibonacci
15.40
15.77
15.99
16.36
16.73
16.95
17.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Apr 28, 2024, 01:39 PM
Period
Simple
Exponential
MA5
16.10Sell
16.11Sell
MA10
15.89Buy
16.09Buy
MA20
16.28Sell
16.27Sell
MA50
16.93Sell
16.65Sell
MA100
16.51Sell
16.83Sell
MA200
17.37Sell
17.83Sell
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 16.09, while Verona Pharma Plc’s (VRNA) share price is $16.09, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 16.83, while Verona Pharma Plc’s (VRNA) share price is $16.09, making it a Sell.
Verona Pharma Plc’s (VRNA) stock price is $16.09 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 16.93, creating a Sell signal.
Verona Pharma Plc’s (VRNA) stock price is $16.09 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 16.51, creating a Sell signal.
Verona Pharma Plc’s (VRNA) stock price is $16.09 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 17.37, creating a Sell signal.

Verona Pharma (VRNA) Technical Indicators

Apr 28, 2024, 01:39 PM
Name
Value
Implied Action
RSI (14)
46.85
Neutral
STOCH (9,6)
69.05
Neutral
STOCHRSI (14)
56.38
Neutral
MACD (12,26)
-0.28
Sell
ADX (14)
11.84
Buy
Williams %R
-51.24
Buy
CCI (14)
-18.19
Neutral
ATR (14)
0.84
-
Ultimate Oscillator
43.65
Neutral
ROC
-0.86
Sell
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 46.85, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 11.84, creating a Buy signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is -18.19, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is -0.86, creating a Sell signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Sell.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 46.85, which suggests VRNA is a Neutral.
      What is VRNA’s MACD?
      VRNA’s MACD is -0.28, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 16.10, which suggests VRNA is a Sell.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 16.28, which suggests VRNA is a Sell.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 16.93, which suggests VRNA is a Sell.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 17.37, which suggests VRNA is a Sell.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -51.24, which suggests VRNA is a Buy.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is -18.19, which suggests VRNA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis